Genetics of Glucose regulation in Gestation and Growth

The Gen3G study aims to increase the understanding of biological, environmental and genetic determinants of glucose regulation during pregnancy and their impact on fetal development.

Overview

Acronym
Gen3G
Investigators
M.D. Marie-France Hivert
University of Sherbrooke
M.D. Patrice Perron
University of Sherbrooke
Dr. Luigi Bouchard
University of Sherbrooke
Contacts
M.D. Marie-France Hivert
University of Sherbrooke
M.D. Patrice Perron
University of Sherbrooke
Dr. Luigi Bouchard
University of Sherbrooke

General Design

Study design
Cohort
Start - End Year
2010 -
General Information on Follow Up (profile, frequency)
Data and samples were collected at two time points during pregnancy and at delivery. The first research visit was between 5 and 16 weeks of gestation and the second visit was planned between 24 and 30 weeks. The follow-up of mothers and children 3-5 years postpartum is in process.
Recruitment Target
  • Families
Number of Participants
1,888
Number of Participants with Biological Samples
1,300
Supplementary information about number of participants
Mothers: 1,034 participants
Children: 854 participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

To get access to data and/or samples an official written request is required. To get the proposal form contact one of the principal investigators.

Sector of research

Possible Access to Data Possible Access to Biosamples
Investigators from the public sector
Investigators from the private sector
Investigators from not-for-profit organization

Transfer

Possible Access to Data Possible Access to Biosamples
Can leave the study facility
Can leave the country

no personal identification, protected transfer of data, protocol IRB approved by receiving institution, financial support as required, DTA/MTA is also required before any transfer

Cost

Possible Access to Data Variable Cost
Possible Access to Biosamples Variable Cost

cost depends on extent of work to prepare dataset, and/or samples handling

Cost reduction for co-analyses

Possible Access to Data
Possible Access to Biosamples

Marker Papers

Guillemette L, Allard C, Lacroix M, Patenaude J, Battista MC, Doyon M, Moreau J, Ménard J, Bouchard L, Ardilouze JL, Perron P, Hivert MF. Genetics of Glucose regulation in Gestation and Growth (Gen3G): a prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada. BMJ Open. 2016 Feb 3;6(2):e010031.

PUBMED 26842272

Taschereau ‍‍A, Doyon M,Arguin M,Allard ‍‍C, Desgagné V, Cote ‍‍AM, Massé É, Jacques, PE, Perron P, Hivert MF, Bouchard L. Cohort profile: The Genetics of Glucose regulation in Gestation and Growth (Gen3G) - a prospective prebirth cohort of mother–child pairs in Sherbrooke, Canada, 3- and 5-year post-partum follow

PUBMED 40122564

Timeline

Populations

Gen3G - Mothers
Pregnant women, aged 18 years and older, were recruited during a visit to the blood sampling in pregnancy clinic in Sherbrooke for their first trimester clinical blood samples.

Selection Criteria

Sex
Women only
Minimum age
18
Pregnant Women
  • First trimester
Countries
  • Canada
Canadian Provinces
  • Quebec
Territory
Eastern Townships region
Other Criteria
Women were excluded if they: had known pre-pregnancy diabetes, took medication that influenced glucose tolerance, had glycated haemoglobin (HbA1c) ≥6.5% or 1 h glucose ≥10.3 mmol/L post-50 g GCT, as this was classified as overt diabetes based on 2008 CDA criteria.

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information
All women were invited to participate if they received prenatal care directly at or in a health center affiliated with the CHUS and planned delivery at the CHUS.

Sample Size

Number of Participants
1,034
Number of Participants with Biological Samples
696
Supplementary information about number of participants
First trimester: 1034 participants
Second trimester: 898 participants
Delivery: 854 participants
3 years follow-up: 448 mother-child dyads
5 years follow-up: 521 mother-child dyads
12 years follow: 430 mother-child dyads and still ongoing

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 Gen3G - Mothers - First trimester
  • Questionnaires
  • Physical measures
  • Biosamples
  • Blood
2010 (January) 2013 (June)
1 Gen3G - Mothers - Second trimester
  • Questionnaires
  • Physical measures
  • Biosamples
  • Blood
2010 (May) 2013 (October)
2 Gen3G - Mothers - Delivery
  • Biosamples
  • Administrative databases
  • Cord blood
  • Tissues : Placenta, maternal side
2010 (August) 2014 (January)
3 Gen3G - Mothers 3 years post delivery
  • Questionnaires
  • Physical measures
  • Biosamples
  • Blood
2013 (August) 2017 (March)
4 Gen3G - Mothers 5 years post delivery
  • Questionnaires
  • Physical measures
  • Biosamples
  • Blood
  • Urine
  • Other : stool samples, microbiome analysis
2015 (June) 2019 (March)
5 Gen3G - Mothers 12 years post delivery
  • Questionnaires
  • Cognitive measures
  • Physical measures
  • Biosamples
  • Other : brain MRI
  • Blood
  • Urine
  • Other : stool samples
2021 (August) 2025 (December)
Gen3G - Children
The population is composed of the newborns of the women enrolled in the study.

Selection Criteria

Newborns
Countries
  • Canada
Canadian Provinces
  • Quebec
Territory
Eastern Townships region

Sources of Recruitment

Specific Population
  • Other specific population : Children of the women in Gen3G study

Sample Size

Number of Participants
854
Number of Participants with Biological Samples
604
Supplementary information about number of participants
N=662 cord blood samples N= 694 placenta samples

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 Gen3G - Children - Delivery
  • Physical measures
  • Biosamples
  • Administrative databases
  • Cord blood
  • Tissues : Placenta, fetal and maternal sides
2010 (August) 2014 (January)
1 Gen3G - Children – 3 years post delivery
  • Questionnaires
  • Physical measures
  • Biosamples
  • Saliva
2013 (August) 2017 (March)
2 Gen3G - Children – 5 years post delivery
  • Questionnaires
  • Physical measures
  • Biosamples
  • Other : growth chart
  • Blood
  • Urine
  • Saliva
  • Hair
  • Other : stool samples
2015 (June) 2019 (March)
3 Gen3G - Children – 12 years post delivery
  • Questionnaires
  • Cognitive measures
  • Physical measures
  • Biosamples
  • Blood
  • Urine
  • Saliva
  • Hair
  • Other : stool samples
2021 (August) 2025 (December)

Participating Studies

Acronym Name Study design Countries

Harmonization Initiatives Included

Acronym Name

Datasets

Name Data Collection Events Variables

Areas of Information Collected

Socio-demographic and economic characteristics
Death
Lifestyle and behaviours
Physical measures and assessments
Birth, pregnancy and reproductive health history
Laboratory measures
Perception of health, quality of life, development and functional limitations
Cognition, personality and psychological measures and assessments
Diseases
Life events, life plans, beliefs and values
Symptoms and signs
Preschool, school and work life
Medication and supplements
Social environment and relationships
Non-pharmacological interventions
Physical environment
Health and community care services utilization
Administrative information

Variables Content Summary

Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected

Networks

Acronym Name Harmonization Initiatives Individual Studies
Last Update: 2026-07-07T14:50:38.715